Table 1.
Substrate/Coating | Coating strategy | In vitro/in vivo studies | Ref. |
---|---|---|---|
Duraflo™ heparin and sirolimus | Layer-by-layer | APTT assay, drug release studies (drug eluiting stent) | 76 |
Amino-silanized titanium/Heparin and collagen Type-IV | Layer by layer | platelet adhesion test, APTT assay | 77 |
NiTi shape memory alloy/Heparin | UV-pretreatment and physical adsorption | hemolytic tests, dynamic clotting time experiments, platelet binding tests | 78 |
316L stainless steel/heparin | Chemical conjugation using dopamine and HMA | APTT assay, HUVECs & HASMCs proliferation studies/subcutaneous implantation in white rabbits | 78 |
Nanofibers/Heparin | Chemical conjugation using diamino-poly(ethylene glycol) as linker | Antitrombogenic activity tests/implantation in rats | 79 |
Titanium/PEG and Heparin | carbodiimide covalent coupling method | APTT assay/HUVECs adhesion and proliferation studies | 80 |
APTT: activated partial thromboplastin time, HUVECs: Human Umbilical Vein Endothelial Cells, HASMCs: Human Artery smooth muscle cells, HMA: hexamethylenediamine.